← Leaderboards
Jayakumar Rajadas
Stanford University
$2,361,651
Attributed
$5,797,142
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,797,142 · 2
By mechanism
R01$5,797,142 · 2
Top collaborators
- Joseph C Wu9 shared
- Wing H. Wong4 shared
- Ronglih Liao1 shared
Most similar at Stanford University
Same institution · by research overlap
- Joseph C Wu$80,370,369
- Paul W. Burridge$6,528,957
- Thomas None Quertermous$63,279,401
- Nazish Sayed$4,856,076
- Mark Mercola$44,191,191
Others in their field
Other Emerging Leaders on “Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,487,925
- Lynn Briscoe · Leidos Biomedical Research, Inc.$121,890,535
- Yunda Huang · Fred Hutchinson Cancer Center$58,111,165
- Leonard Freedmand · Leidos Biomedical Research, Inc.$57,401,321
- John Damon Chodera · Sloan-Kettering Inst Can Research$53,758,943
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$33,980,897
Research focus
ScreeningCardiac MyocytesHeartCellsSignal TransductionInduced Pluripotent Stem CellPrevent3-DimensionalCardiacCell CommunicationBioinformaticsBiocompatible MaterialsGenomicsCaucasiansCandidate Disease GeneDrug RepurposingCancer TherapyEndothelial CellsDoxorubicinCancer SurvivorDrug Delivery SystemsFibroblastsCell LineChemotherapy
Grant awards (9)
Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens$769,543
R01 · FY2025 · HL
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics$603,459
R01 · FY2025 · HL
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics$599,103
R01 · FY2024 · HL
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening$583,765
R01 · FY2024 · HL
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics$620,773
R01 · FY2023 · HL
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening$595,679
R01 · FY2023 · HL
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening$768,819
R01 · FY2022 · HL
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics$628,643
R01 · FY2022 · HL
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening$627,358
R01 · FY2021 · HL